UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 4, 2017 4:01 P.M.

Form:	S-3
CIK: 0001674416 Company Name: CRISPR Therapeutics AG File Number: 333-221491